David Celentano

Last updated
David DuPuy Celentano
Born1951 (age 72–73)
NationalityAmerican
Education Johns Hopkins University BA, MHS, ScD
Occupation Epidemiologist
Known for HIV/AIDS and STI research

David DuPuy Celentano (born 1951) is a noted epidemiologist and professor who has contributed significantly to the promotion of research on HIV/AIDS and other sexually transmitted infections (STIs). He is the Charles Armstrong chair of the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. [1] He holds joint appointments with the school’s departments of Health Policy and Management, Health Behavior and Society, and International Health, and the Johns Hopkins University School of Medicine’s Division of Infectious Diseases.

Contents

Education and professional experience

Celentano graduated with a Bachelor of Arts (BA) degree in psychology from Johns Hopkins University in 1972, later earning a Master of Health Science (MHS) degree in mental hygiene (1975) and Doctor of Science (ScD) degree in behavioral sciences (1977) from the Johns Hopkins School of Hygiene and Public Health (now the Bloomberg School of Public Health). He began his professional career as an addictions counselor at the University of Maryland Hospital in Baltimore, Maryland, later working as a research specialist for the Maryland Department of Health and Mental Hygiene. In 1976, Celentano began working as a research associate in the Office of Health and Manpower Studies, School of Health Services at Johns Hopkins University.

He returned to the School of Public Health in 1978 as a faculty member in the Department of Behavioral Sciences before becoming the head of the Division of Behavioral Sciences and Health Education in the Department of Health Policy and Management in 1987. In 1996, Celentano joined the Department of Epidemiology and three years later, was appointed director of the Infectious Disease track. In 2005, Celentano became deputy chairman, later serving as interim chairman from 2008-2009. He was appointed as the inaugural Charles Armstrong Chair of the Department of Epidemiology in 2009. [2]

Research interests

Celentano’s research integrates behavioral science theory and research with epidemiology methods in the study of behavioral and social epidemiology. [3] While originally trained in a chronic disease paradigm (alcoholism and cancer control), he began his research in HIV/AIDS and STIs in the early 1980s. He has worked on some of the major cohort studies AIDS Linked to the Intravenous Experience (ALIVE), [4] Multicenter AIDS Cohort Study (MACS) [5] in HIV epidemiology, as well as conducted intervention research in the USA for heterosexual men and women, injection drug users, and young men who have sex with men. [1]

In 1990, Celentano turned to international research when he began a long-term collaboration with Chiang Mai University in northern Thailand. He has worked on and directed numerous HIV/AIDS and STI epidemiological investigations and preventive interventions. He and his collaborators have demonstrated that a behavioral intervention with young military conscripts lead to a 7-fold reduction in incident STDs and halved the HIV incidence rate. [6] In addition, the role of STDs and alcohol use on HIV acquisition has been documented. [7] [8] [9] More recently, his group has conducted a prospective study of hormonal contraception in relation to HIV seroconversion, a study with significant family planning policy and health implications. [10] [11] Celentano recently completed four NIH-supported studies in Thailand, focusing on interventions to influence the association between opiate use, methamphetamine use, and other drugs on HIV. The focus of these interventions was to harness indigenous peer networks for risk reduction.

He was the Thailand principal investigator (PI) of Project Accept/HPTN 043, which showed the strong influence of community mobilization, HIV counseling and testing at the village level with post-test support services reduced behavioral risk and increased HIV counseling and testing to 72% of at-risk villagers in three years. [12] Other work addresses the use of antiretroviral treatment as HIV prevention (HPTN 052) [13] which was cited by Science as the major scientific breakthrough of 2011 and opioid substitution therapy as HIV prevention (NPTN 058) for persons who inject drugs. New research includes a community-randomized trial of methods to link men who have sex with men with needed health and psychological health services in India, and studies of seek, test, treat and retain drug users with HIV care in India and Vietnam. [14] Celentano is a mentor to eight Doctor of Public Health (DrPH) degree students from Abu Dhabi, United Arab Emirates and is doing public health practice in the Kingdom of Saudi Arabia and the State of Qatar with Ministry of Health funding in collaboration with Ernst & Young MENA (Middle East and North Africa).

Honors and awards

Society membership

Related Research Articles

<span class="mw-page-title-main">Safe sex</span> Ways to reduce the risk of acquiring STIs

Safe sex is sexual activity using methods or contraceptive devices to reduce the risk of transmitting or acquiring sexually transmitted infections (STIs), especially HIV. "Safe sex" is also sometimes referred to as safer sex or protected sex to indicate that some safe sex practices do not eliminate STI risks. It is also sometimes used colloquially to describe methods aimed at preventing pregnancy that may or may not also lower STI risks.

The spread of HIV/AIDS has affected millions of people worldwide; AIDS is considered a pandemic. The World Health Organization (WHO) estimated that in 2016 there were 36.7 million people worldwide living with HIV/AIDS, with 1.8 million new HIV infections per year and 1 million deaths due to AIDS. Misconceptions about HIV and AIDS arise from several different sources, from simple ignorance and misunderstandings about scientific knowledge regarding HIV infections and the cause of AIDS to misinformation propagated by individuals and groups with ideological stances that deny a causative relationship between HIV infection and the development of AIDS. Below is a list and explanations of some common misconceptions and their rebuttals.

Men who have sex with men (MSM) are men who engage in sexual activity with other men, regardless of their sexual orientation or sexual identity. The term was created by epidemiologists in the 1990s, to better study and communicate the spread of sexually transmitted infections such as HIV/AIDS between all sexually active males, not strictly those identifying as gay, bisexual, pansexual or various other sexualities, but also for example male prostitutes. The term is often used in medical literature and social research to describe such men as a group. It does not describe any specific kind of sexual activity, and which activities are covered by the term depends on context. The alternative term "males who have sex with males" is sometimes considered more accurate in cases where those described may not be legal adults.

Syndemics is the evaluation of how social and health conditions arise, in what ways they interact, and what upstream drivers may produce their interactions. The word is a blend of "synergy" and "epidemics". The idea of syndemics is that no disease exists in isolation and that often population health can be understood through a confluence of factors that produces multiple health conditions that afflict some populations and not others. Syndemics are not like pandemics ; instead, syndemics reflect population-level trends within certain states, regions, cities, or towns.

<span class="mw-page-title-main">HIV/AIDS</span> Spectrum of conditions caused by HIV infection

The human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system. It can be managed with treatment. Without treatment it can lead to a spectrum of conditions including acquired immunodeficiency syndrome (AIDS). Effective treatment for HIV-positive people involves a life-long regimen of medicine to suppress the virus, making the viral load undetectable. There is no vaccine or cure for HIV. An HIV-positive person on treatment can expect to live a normal life, and die with the virus, not of it.

Economic epidemiology is a field at the intersection of epidemiology and economics. Its premise is to incorporate incentives for healthy behavior and their attendant behavioral responses into an epidemiological context to better understand how diseases are transmitted. This framework should help improve policy responses to epidemic diseases by giving policymakers and health-care providers clear tools for thinking about how certain actions can influence the spread of disease transmission.

<span class="mw-page-title-main">Sexually transmitted infection</span> Infection transmitted through human sexual behavior

A sexually transmitted infection (STI), also referred to as a sexually transmitted disease (STD) and the older term venereal disease (VD), is an infection that is spread by sexual activity, especially vaginal intercourse, anal sex, oral sex, or sometimes manual sex. STIs often do not initially cause symptoms, which results in a risk of transmitting them on to others. The term sexually transmitted infection is generally preferred over sexually transmitted disease or venereal disease, as it includes cases with no symptomatic disease. Symptoms and signs of STIs may include vaginal discharge, penile discharge, ulcers on or around the genitals, and pelvic pain. Some STIs can cause infertility.

Frederick Wabwire-Mangen is a Ugandan physician, public health specialist and medical researcher. Currently he is Professor of Epidemiology and Head of Department of Epidemiology & Biostatistics at Makerere University School of Public Health. Wabwire-Mangen also serves as the Chairman of Council of Kampala International University and a founding member of Accordia Global Health Foundation’s Academic Alliance

<span class="mw-page-title-main">HIV-affected community</span> Medical condition

The affected community is composed of people who are living with HIV and AIDS, plus individuals whose lives are directly influenced by HIV infection. This originally was defined as young to middle aged adults who associate with being gay or bisexual men, and or injection drug users. HIV-affected community is a community that is affected directly or indirectly affected by HIV. These communities are usually influenced by HIV and undertake risky behaviours that lead to a higher chance of HIV infection. To date HIV infection is still one of the leading cause of deaths around the world with an estimate of 36.8 million people diagnosed with HIV by the end of 2017, but there can particular communities that are more vulnerable to HIV infection, these communities include certain races, gender, minorities, and disadvantaged communities. One of the most common communities at risk is the gay community as it is commonly transmitted through unsafe sex. The main factor that contributes to HIV infection within the gay/bisexual community is that gay men do not use protection when performing anal sex or other sexual activities which can lead to a higher risk of HIV infections. Another community will be people diagnosed with mental health issues, such as depression is one of the most common related mental illnesses associated with HIV infection. HIV testing is an essential role in reducing HIV infection within communities as it can lead to prevention and treatment of HIV infections but also helps with early diagnosis of HIV. Educating young people in a community with the knowledge of HIV prevention will be able to help decrease the prevalence within the community. As education is an important source for development in many areas. Research has shown that people more at risk for HIV are part of disenfranchised and inner city populations as drug use and sexually transmitted diseases(STDs) are more prevalent. People with mental illnesses that inhibit making decisions or overlook sexual tendencies are especially at risk for contracting HIV.

HIV prevention refers to practices that aim to prevent the spread of the human immunodeficiency virus (HIV). HIV prevention practices may be undertaken by individuals to protect their own health and the health of those in their community, or may be instituted by governments and community-based organizations as public health policies.

For the American comedian and raconteur, see Myron Cohen.

Education is recognized as a social determinant of health. Education has also been identified as a social vaccine against contracting HIV. Research suggests a negative linear relationship between educational attainment and HIV infection rate, especially the educational attainment of women and girls.

<span class="mw-page-title-main">Thomas J. Coates</span> American HIV/AIDS researcher

Thomas J. Coates is the Director of the multi-campus University of California Global Health Institute, a UC-wide initiative established to improve health and reduce the burden of disease throughout the world. He is Professor Emeritus at the UCLA David Geffen School of Medicine and Founding Director of the UCLA Center for World Health, a joint initiative of the David Geffen School of Medicine at UCLA and UCLA Health, He has conducted extensive research in the realm of HIV and is the Michael and Sue Steinberg Endowed Professor of Global AIDS Research within the Division of Infectious Diseases at UCLA and Distinguished Professor of Medicine. Health-related behavior is of particular interest to Coates. Throughout his career as a health expert, his theory-based research has been focused on interventions aimed at reducing risks and threats to health

Risky sexual behavior is the description of the activity that will increase the probability that a person engaging in sexual activity with another person infected with a sexually transmitted infection will be infected, become unintentionally pregnant, or make a partner pregnant. It can mean two similar things: the behavior itself, and the description of the partner's behavior.

Jeffrey T. Parsons is an American psychologist, researcher, and educator; he was a Distinguished Professor of Psychology at Hunter College and The Graduate Center of the City University of New York (CUNY) and was the Director of Hunter College's Center for HIV/AIDS Educational Studies & Training, which he founded in 1996. Parsons was trained as a developmental psychologist and applied this training to understand health, with a particular emphasis on HIV prevention and treatment. He was known for his research on HIV risk behaviors of gay, bisexual, and other men who have sex with men (GBMSM), HIV-related syndemics, and sexual compulsivity. He resigned his positions at CUNY on July 3, 2019, following a year-long university investigation of misconduct allegations against him. In 2023, the U.S. Attorney's Office announced that he was required to pay a $375,000 settlement for engaging in fraud against the federal government for many years.

Elizabeth Anne Bukusi FAAS is a research professor working within the field of obstetrics and gynaecology, and global health. Bukusi's main areas of research focus around sexually transmitted infections, women's health, reproductive health, and HIV care, prevention and treatment. Bukusi is the Chief Research Officer at the Kenya Medical Research Institute (KEMRI) and led a "landmark" study on the use of PrEP in Kenya.

Fred Mhalu is a microbiologist and medical researcher from Tanzania. His main area of study revolves around infectious diseases and intervention. Ever since 1986, he has been a main contributor to the information about AIDS in Africa. As a co-coordinator of a Tanzanian-Swedish research collaboration called TANSWED, he was involved in many research projects that lead to multiple publications in medical journals. His more recent research on HIV/AIDS involves studying breast cancer in HIV prevalent areas, evaluating prevention of mother-to-child-transmission of HIV-1, and observing sexual behaviors of high risk populations for HIV-1.

Sunil Suhas Solomon is an Indian academic and associate professor of Medicine, in the Division of Infectious Diseases, at the Johns Hopkins University School of Medicine. Dr Sunil is also the chairman of YRG Care. His work revolves around epidemiology, clinical management and access to HIV and HCV services for at risk populations.

<span class="mw-page-title-main">Michel Alary</span> Canadian academic, doctor

Michel Alary is a Canadian academic, doctor of preventive medicine and a health researcher. He is a Professor of Social and Preventive Medicine at Université Laval and the director of population health research at the Research Centre of the CHU de Quebec – Université Laval. He also serves as a Medical Consultant at the Institut national de santé publique du Québec. Alary has published over 260 research papers and has produced major reports for the World Bank and UNAIDS about HIV in sub-Saharan Africa. He also evaluated the Bill & Melinda Gates Foundation's India AIDS Initiative for which his project received the Avahan Recognition Award. He has conducted epidemiological and preventive research on blood-borne infections, HIV and other Sexually Transmitted Diseases (STD) among the most vulnerable populations in developed and developing countries.

<span class="mw-page-title-main">Frits van Griensven</span> Dutch public health scientist and epidemiologist

Godefridus Johannes Petrus "Frits" van Griensven is a pioneering Dutch scientist in epidemiology, sociology and public health. Most of his work is on addressing the HIV epidemic among men who have sex with men and other HIV key populations.

References

  1. 1 2 "Faculty Profile". Johns Hopkins Bloomberg School of Public Health. Retrieved 27 August 2015.
  2. ↑ "David Celentano Named Charles Armstrong Chair and Professor of Epidemiology". Johns Hopkins Bloomberg School of Public Health. 18 September 2009.
  3. ↑ "Google Scholar Citations". scholar.google.com. Retrieved 2015-08-27.
  4. ↑ Vlahov, D.; Anthony, J. C.; Munoz, A.; Margolick, J.; Nelson, K. E.; Celentano, D. D.; Solomon, L.; Polk, B. F. (1991-01-01). "The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants". NIDA Research Monograph. 109: 75–100. ISSN   1046-9516. PMID   1661376.
  5. ↑ Kaslow, R. A.; Ostrow, D. G.; Detels, R.; Phair, J. P.; Polk, B. F.; Rinaldo, C. R. (1987-08-01). "The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants". American Journal of Epidemiology. 126 (2): 310–318. doi:10.1093/aje/126.2.310. ISSN   0002-9262. PMID   3300281.
  6. ↑ Celentano, D. D.; Nelson, K. E.; Lyles, C. M.; Beyrer, C.; Eiumtrakul, S.; Go, V. F.; Kuntolbutra, S.; Khamboonruang, C. (1998-03-26). "Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program". AIDS. 12 (5): F29–36. doi: 10.1097/00002030-199805000-00004 . ISSN   0269-9370. PMID   9543437. S2CID   39577722.
  7. ↑ Zenilman, J. M.; Hook, E. W.; Shepherd, M.; Smith, P.; Rompalo, A. M.; Celentano, D. D. (1994-08-01). "Alcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infection". Sexually Transmitted Diseases. 21 (4): 220–225. doi: 10.1097/00007435-199407000-00008 . ISSN   0148-5717. PMID   7974074. S2CID   24737791.
  8. ↑ Celentano, David D.; Valleroy, Linda A.; Sifakis, Frangiscos; MacKellar, Duncan A.; Hylton, John; Thiede, Hanne; McFarland, Willi; Shehan, Douglas A.; Stoyanoff, Susan R. (2006-04-01). "Associations between substance use and sexual risk among very young men who have sex with men". Sexually Transmitted Diseases. 33 (4): 265–271. doi: 10.1097/01.olq.0000187207.10992.4e . ISSN   0148-5717. PMID   16434886. S2CID   11824437.
  9. ↑ Go, Vivian F.; Solomon, Suniti; Srikrishnan, Aylur K.; Sivaram, Sudha; Johnson, Sethulakshmi C.; Sripaipan, Teerada; Murugavel, Kailapuri G.; Latkin, Carl; Mayer, Kenneth (2007-12-01). "HIV rates and risk behaviors are low in the general population of men in Southern India but high in alcohol venues: results from 2 probability surveys". Journal of Acquired Immune Deficiency Syndromes. 46 (4): 491–497. doi:10.1097/qai.0b013e3181594c75. ISSN   1525-4135. PMC   2884173 . PMID   18077840.
  10. ↑ Morrison, Charles S.; Chen, Pai-Lien; Kwok, Cynthia; Richardson, Barbra A.; Chipato, Tsungai; Mugerwa, Roy; Byamugisha, Josaphat; Padian, Nancy; Celentano, David D. (2010-07-17). "Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling". AIDS. 24 (11): 1778–1781. doi:10.1097/QAD.0b013e32833a2537. ISSN   1473-5571. PMC   3148067 . PMID   20588106.
  11. ↑ Morrison, Charles S.; Richardson, Barbra A.; Mmiro, Francis; Chipato, Tsungai; Celentano, David D.; Luoto, Joanne; Mugerwa, Roy; Padian, Nancy; Rugpao, Sungwal (2007-01-02). "Hormonal contraception and the risk of HIV acquisition". AIDS. 21 (1): 85–95. doi: 10.1097/QAD.0b013e3280117c8b . ISSN   0269-9370. PMID   17148972. S2CID   52871769.
  12. ↑ Khumalo-Sakutukwa, Gertrude; Morin, Stephen F.; Fritz, Katherine; Charlebois, Edwin D.; van Rooyen, Heidi; Chingono, Alfred; Modiba, Precious; Mrumbi, Khalifa; Visrutaratna, Surasing (2008-12-01). "Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand". Journal of Acquired Immune Deficiency Syndromes. 49 (4): 422–431. doi:10.1097/QAI.0b013e31818a6cb5. ISSN   1525-4135. PMC   2664736 . PMID   18931624.
  13. ↑ Cohen, Myron S.; Chen, Ying Q.; McCauley, Marybeth; Gamble, Theresa; Hosseinipour, Mina C.; Kumarasamy, Nagalingeswaran; Hakim, James G.; Kumwenda, Johnstone; Grinsztejn, Beatriz (2011-08-11). "Prevention of HIV-1 infection with early antiretroviral therapy". The New England Journal of Medicine. 365 (6): 493–505. doi:10.1056/NEJMoa1105243. ISSN   1533-4406. PMC   3200068 . PMID   21767103.
  14. ↑ Go, VF; Frangakis, C; Minh, NL; Latkin, C; Ha, TV; Mo, TT; Sripaipan, T; Davis, WW; Zelaya, C; Vu, PT; Celentano, DD; Quan, VM (2015). "Efficacy of a Multi-level Intervention to Reduce Injecting and Sexual Risk Behaviors among HIV-Infected People Who Inject Drugs in Vietnam: A Four-Arm Randomized Controlled Trial". PLOS ONE. 10 (5): e0125909. Bibcode:2015PLoSO..1025909G. doi: 10.1371/journal.pone.0125909 . PMC   4444299 . PMID   26011427.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.